Innovative signaling inhibition in breast cancer using folate-targeted lipid nanoparticles.

Prize: Fellowship awarded competitively

Description

Gilead GÉNESE, 26592 (2025-2027).
Awarded date2025
Granting OrganisationsGilead Génese